MAP is the leading global meeting dedicated to understanding molecular developments that can help in making cancer treatment more personalised.
The congress is at the interface between basic science and clinical application, and covers a broad range of tumours types, molecular targets and therapies.
By attending the Molecular Analysis for Precision Oncology Congress 2022, participants will gain deeper insights into precision medicine, cancer-stromal interactions, clonal evolution, metastatic dissemination and drug response and resistance.
MAP is the result of a close partnership among Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer, all committed to offer the best care to people with cancer worldwide, through oncology education and research.
How can I participate at MAP 2022?
At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate their presence at our congress.
For sponsorship information and a prospectus please contact:
Head of Strategic Partnerships
Strategic Projects Manager
We look forward to hearing from you!